News
The positive reaction to Hinge Health’s initial public offering from Wall Street has brought optimism back to digital health.
In this week’s edition of InnovationRx, we look at how Hinge Health’s successful IPO may be a trendsetter, Indian billionaire ...
4d
Barchart on MSNShould You Buy Hinge Health After the HNGE Stock IPO?Investing in companies that have recently gone public is a strategy for individuals with a higher risk appetite. Typically, ...
Physical therapy company Hinge Health finally went public Thursday. Its CEO says it's banking on AI to automate more care and ...
Hinge Health, Inc. engages in the development of technology platform for the treatment of musculoskeletal (MSK) conditions. Its platform addresses a broad spectrum of MSK care, from acute injury to ...
Hinge Health initially aimed to sell nearly 14 million shares in a $28-$32 range, with final pricing set at the higher end of ...
8d
Benzinga on MSNHinge Health Rises on NYSE Debut After Pricing IPO at Top of RangeHinge Health shares rose in their New York Stock Exchange debut on Thursday, according to The Wall Street Journal. Shares opened at $39.25 after pricing its IPO at $32 per share, the top of its ...
Apple's anticipated AR Glasses are expected to be released in 2026. These are five features it might have when it launches ...
Hinge Health shares jump 17% in stock market debut, setting the stage for digital health IPO revival
Shares of Hinge Health jumped 22% above the initial public offering price in the company's New York Stock Exchange debut ...
The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's ...
Hinge Health is betting that Wall Street is ready for a new digital health offering after a difficult few years for that market.
Researchers at Weill Cornell Medicine have discovered how a parasite that causes malaria when transmitted through a mosquito ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results